| Name | Title | Contact Details |
|---|---|---|
Christopher Nellum |
Director of Policy and Research | Profile |
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.
The first regulator approved diamond commodity, unlocking a $1.2 trillion natural resource for institutional investors. The commodity is physical and transacted using an integrated a blockchain token.
Light was founded in 2013 and is based in Palo Alto, CA. The company is an early-stage startup and is in a pre-launch stage.
Point Pickup Technologies (PPUP) is a technology enabled platform (services) company disrupting legacy transportation models to solve middle and last mile delivery.